Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.

Add to Collection

2008 Mar Others D Khutsoane, SK Sharma, M Almustafa… - Diabetes, Obesity …, 2008 - Wiley Online Library 111

Full Author : ['Khutsoane, D', 'Sharma, S K', 'Almustafa, M', 'Jang, H C', 'Azar, S T', 'Danciulescu, R', 'Shestakova, M', 'Ayad, N M A', 'Guler, S', 'Bech, O M']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2008
Cited by : 107.0

AIM: The Physicians' Routine Evaluation of Safety and Efficacy of NovoMix 30 Therapy (PRESENT) study aims to assess the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in patients with type 2 diabetes mellitus in routine clinical practice. ME..... Read More

Keywords : ["biphasic insulin aspart treatment improve glycaemic control", "clinical practice set experience", "type diabetes", "present study", "patient"]
PubMed Link : https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1463-1326.2007.00826.x
Google Scholar Link : https://scholar.google.com/scholar?cites=8619517153013357868&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.